Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weng Ieong Tou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|April 4, 2012
In silico investigation of potential SRC kinase ligands from traditional Chinese medicineWeng Ieong Tou, Calvin Yu-Chian Chen
Drug Discovery Today|May 7, 2013
How to design a drug for the disordered proteins?Calvin Yu-Chian Chen, Weng Ieong Tou
Drug Discovery Today|November 5, 2013
May disordered protein cause serious drug side effect?Weng Ieong Tou, Calvin Yu-Chian Chen
Journal of Biomolecular Structure & Dynamics|June 15, 2012
Traditional Chinese medicine as dual guardians against hypertension and cancer?Weng Ieong Tou, Calvin Yu-Chian Chen
Scientific Reports|February 5, 2013
Drug design for neuropathic pain regulation from traditional Chinese medicineWeng Ieong Tou, Su-Sen Chang, Cheng-Chun Lee, et al.
Journal of Molecular Modeling|December 10, 2015
Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutantsWeng Ieong Tou, Kun-Lung Chang, Tung-Ti Chang, et al.
Scientific Reports|July 23, 2014
Developing hypothetical inhibition mechanism of novel urea transporter B inhibitorMin Li, Weng Ieong Tou, Hong Zhou, et al.
Acta Pharmacologica Sinica|May 31, 2016
Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding modelJian-Hua Ran, Min Li, Weng-Ieong Tou, et al.
Journal of Biomolecular Structure & Dynamics|April 23, 2013
Molecular level activation insights from a NR2A/NR2B agonistWeng Ieong Tou, Su-Sen Chang, Dongchuan Wu, et al.
Health Science Reports|July 5, 2023
Clinical characteristics of COVID-19 patients infected by the Omicron variants in Macao, China: A cross-sectional studyHou Hon Cheong, Fong I Sio, Chi Chung Chan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|April 4, 2012
In silico investigation of potential SRC kinase ligands from traditional Chinese medicineWeng Ieong Tou, Calvin Yu-Chian Chen
Drug Discovery Today|May 7, 2013
How to design a drug for the disordered proteins?Calvin Yu-Chian Chen, Weng Ieong Tou
Drug Discovery Today|November 5, 2013
May disordered protein cause serious drug side effect?Weng Ieong Tou, Calvin Yu-Chian Chen
Journal of Biomolecular Structure & Dynamics|June 15, 2012
Traditional Chinese medicine as dual guardians against hypertension and cancer?Weng Ieong Tou, Calvin Yu-Chian Chen
Scientific Reports|February 5, 2013
Drug design for neuropathic pain regulation from traditional Chinese medicineWeng Ieong Tou, Su-Sen Chang, Cheng-Chun Lee, et al.
Journal of Molecular Modeling|December 10, 2015
Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutantsWeng Ieong Tou, Kun-Lung Chang, Tung-Ti Chang, et al.
Scientific Reports|July 23, 2014
Developing hypothetical inhibition mechanism of novel urea transporter B inhibitorMin Li, Weng Ieong Tou, Hong Zhou, et al.
Acta Pharmacologica Sinica|May 31, 2016
Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding modelJian-Hua Ran, Min Li, Weng-Ieong Tou, et al.
Journal of Biomolecular Structure & Dynamics|April 23, 2013
Molecular level activation insights from a NR2A/NR2B agonistWeng Ieong Tou, Su-Sen Chang, Dongchuan Wu, et al.
Health Science Reports|July 5, 2023
Clinical characteristics of COVID-19 patients infected by the Omicron variants in Macao, China: A cross-sectional studyHou Hon Cheong, Fong I Sio, Chi Chung Chan, et al.
Pageof 1